Key senior hire will partner with Allison Ceraso, President and CCO, bolstering agency leadership amongst continued network momentum
Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Subscribe To Our Newsletter & Stay Updated
